2024 HCPCS Code J9349
Injection, tafasitamab-cxix, 2 mg
| Short Description | Inj., tafasitamab-cxix |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2021 |
| HCPCS Code Added Date | April 01, 2021 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J3364 - Urokinase 5000 iu injection
- J3365 - Urokinase 250,000 iu inj
- J3370 - Vancomycin hcl injection
- J3371 - Inj, vancomycin hcl (mylan)
- J3372 - Inj, vancomycin hcl (xellia)
- J3380 - Inj vedolizumab iv 1 mg
- J3385 - Velaglucerase alfa
- J3393 - Inj, betibeglogene autotemce
- J3394 - Inj, lovotibeglogene autotem
- J3396 - Verteporfin injection
- J3397 - Inj., vestronidase alfa-vjbk
- J3398 - Inj luxturna 1 billion vec g
- J3399 - Inj onase abepar-xioi treat
- J3400 - Triflupromazine hcl inj
- J3401 - Vyjuvek 5x10^9pfu/ml, 0.1 ml
- J3410 - Hydroxyzine hcl injection
- J3411 - Thiamine hcl 100 mg
- J3415 - Pyridoxine hcl 100 mg
- J3420 - Vitamin b12 injection
- J3424 - Inj hydroxocobalamin iv 25mg